Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects

A 65-year-old male, Parkinson’s disease patient, was evaluated for GPR109A expression, niacin index, UPDRS scale, handwriting test, and quality of sleep with and without niacin treatment. The evaluation was repeated 3 months after niacin was stopped. Niacin modulated the abovementioned parameters an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakade, Chandramohan, Chong, Raymond, Bradley, Eric, Morgan, John C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527813/
https://www.ncbi.nlm.nih.gov/pubmed/26273459
http://dx.doi.org/10.1002/ccr3.232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527813/
https://www.ncbi.nlm.nih.gov/pubmed/26273459
http://dx.doi.org/10.1002/ccr3.232

Ejemplares similares